WeVote
Log In

Bill

YA

Bill

HR 9090

Advancing Menopause Care and Mid-Life Women’s Health Act

119th Congress Introduced by Yassamin Ansari and 7 co-sponsors

The bill creates a federal framework to expand research, data, and coordinated, integrated care for menopause and mid-life women, addressing disparities and access.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 9090

Overview

  • Bill: HR 9090
  • Session: 119th Congress
  • Title: Advancing Menopause Care and Mid-Life Women’s Health Act
  • Introduced: June 2, 2026 by Rep. Yvette Clarke (co-sponsored by Rep. Clarke)
  • Committee: Energy and Commerce
  • Purpose: To improve menopause care and mid-life women’s health through expanded federal research, public health initiatives, training, and centers of excellence, with a focus on perimenopause, menopause, and postmenopausal health.

Main Purpose and Intent

  • Establish a comprehensive federal framework to advance understanding, prevention, early detection, and treatment of menopausal symptoms and related mid-life health conditions.
  • Promote integrated, evidence-based care for mid-life women through research, public health programs, education, workforce training, and designated Centers of Excellence.
  • Address health disparities (including rural-urban and underserved populations) and coordinate across federal agencies.

Key Provisions

1) Research Expansion and Coordination (Section 2)

  • Adds new NIH research section (Sec. 404P) to coordinate across NIH institutes and offices on:
    • Impacts of perimenopause, menopause, and postmenopause on physical, oral, mental, behavioral, and cognitive health.
    • Prevention of adverse health outcomes during menopausal transitions.
    • Health disparities (e.g., rural vs urban/suburban differences).
    • Development of integrated, collaborative care approaches (both non-pharmacological and pharmacological).
  • Grants to eligible entities to support:
    • Biomedical/public health research and diagnostics for perimenopause and menopausal conditions.
    • Clinical and translational research on mid-life women’s health.
    • Testing and implementation of evidence-based, integrated care approaches.
  • Eligible entities include teaching hospitals, accredited health-profession schools, minority-serving institutions, academic/research institutions, small businesses, and other appropriate entities.
  • NIH to designate new Research, Condition, and Disease Categorization categories for menopause-related conditions.
  • Expands translational research and outreach to accelerate implementation and equitable delivery of care.

2) Public Health Research and Data Reporting (Section 2, Sec. 310C)

  • Adds Sec. 310C to the Public Health Service Act:

    • Expand public health research on severity/duration of menopausal symptoms and related chronic conditions affecting mid-life health outcomes.
    • Expand health care quality research, including data collection on preventive services and integrated care models.
    • Create and maintain a dashboard (public health surveillance) tracking menopausal symptoms and mid-life health outcomes, and the impact of the act.
    • Conduct occupational health research on workplace stressors and adverse health outcomes related to menopausal symptoms.
    • Promote interagency interagency coordination for new menopause-related initiatives.

  • Funding: Authorization of $25 million per fiscal year from 2027 through 2031 for Secs. 404P and 310C.

3) Public Health Promotion and Prevention (Title III, Part X)

  • Adds Part X provisions to expand public health promotion and prevention for mid-life women's health.
  • Grants to improve early detection, diagnosis, and treatment of perimenopausal/menopausal symptoms and related conditions.
  • Eligible entities include State/local/Tribal health departments and accredited health-profession education entities.
  • Supports care coordination and access to primary/specialty care to improve mid-life health outcomes.
  • Mental health and substance use prevention components to support women experiencing menopausal symptoms.
  • Development of best practices to reduce health disparities, improve access to integrated care, and offer patient-centered counseling and treatments (pharmacological and non-pharmacological).
  • Oversight of safety and effectiveness of new treatments and diagnostic tools, including AI-based devices.
  • Authorization of $10 million per year for 2027–2031.

4) Public Health Awareness, Education, and Outreach (Sec. 399PP–1)

  • National awareness, education, and outreach program on menopause and mid-life health.
  • Distributes educational materials, provides technical assistance to providers and patients, identifies risk factors, and addresses barriers to care.
  • Outreach to Indian Tribes with culturally appropriate materials; allows state/local/tribal customization; prioritizes rural and underserved areas.
  • Maintains an online resources website with webinars, continuing education, and audience-specific materials.
  • Authorization of $10 million per year for 2027–2031.

5) Training Programs for Care Improvement (Section 5)

  • Establishes grants to train health professionals in perimenopause/menopausal care and related conditions.
  • Supports residency programs, fellowships, and other clinical training.
  • Eligible entities include medical/dental/nursing schools, teaching hospitals, residency programs, advanced practice programs, and related training programs.
  • Expands training opportunities to broaden access to primary and specialty care for mid-life health.
  • Authorization of $10 million per year for 2027–2031.

6) Centers of Excellence in Menopause Care and Mid-Life Health (Section 6)

  • Designates Centers of Excellence to improve professional training and care quality.
  • Eligibility includes accredited education entities and community partnerships.
  • Activities include distributing evidence-based resources, focusing on advancements and prevention of related chronic conditions, and ensuring geographic distribution (with emphasis on rural areas).
  • Prioritizes entities serving health professional shortage areas and medically underserved populations.
  • Annual reporting and evaluation of funded projects.
  • Authorization of such sums as necessary for 2027–2031.

7) Reporting Requirement (Section 7)

  • Annual reporting to multiple Senate and House committees, starting two years after enactment, detailing:
    • Federal research activities, awareness/outreach progress, and data on barriers and disparities (especially in rural/underserved areas).
    • Recommendations to expand integrated care and public understanding.
    • Information on related federal activities.

8) Coordination (Section 8)

  • Requires coordination of Act activities with Department of Veterans Affairs, Department of Defense, and other federal entities as appropriate.

Who Is Affected

  • Mid-life women experiencing perimenopause, menopause, and postmenopause.
  • Healthcare providers (physicians, dentists, nurses, pharmacists, PAs, social workers, etc.).
  • Academic and teaching institutions, residency/fellowship programs, and minority-serving institutions.
  • State/local/tribal public health departments.
  • Health systems and hospitals (including those in health professional shortage areas and medically underserved communities).
  • Researchers and industry partners (including small businesses) involved in menopause-related research and care.

Timelines and Funding

  • Authorization of appropriations:
    • Sections 404P and 310C: $25 million annually (FY 2027–FY 2031).
    • Public Health Promotion and Outreach (Sec. 399PP–1): $10 million annually (FY 2027–FY 2031).
    • Training Programs (Sec. 758): $10 million annually (FY 2027–FY 2031).
    • Centers of Excellence (Sec. 399PP–2): Funding “as may be necessary” for 2027–2031.
    • General annual reporting begins two years after enactment and then annually.
  • All provisions coordinate with, and expand, existing Public Health Service Act programs and other HHS activities.
  • The Secretary of Health and Human Services is charged with interagency coordination and public outreach, including a dedicated online resource platform.

Potential Impacts

  • Increased federal investment and coordination in menopause/mid-life women’s health research and care delivery.
  • More knowledge about perimenopause, menopause, postmenopause, and associated chronic conditions, with attention to disparities.
  • Expanded training and education for healthcare professionals to improve care quality and accessibility.
  • Greater emphasis on integrated, patient-centered care models and preventive strategies.
  • Improved public awareness and resources for patients, families, and providers, including culturally competent outreach.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.